DI GIORGIO, Angelo
 Distribuzione geografica
Continente #
AS - Asia 1.616
NA - Nord America 1.266
SA - Sud America 498
EU - Europa 359
Continente sconosciuto - Info sul continente non disponibili 250
AF - Africa 37
OC - Oceania 1
Totale 4.027
Nazione #
US - Stati Uniti d'America 1.211
SG - Singapore 722
BR - Brasile 398
CN - Cina 253
VN - Vietnam 205
HK - Hong Kong 167
IT - Italia 117
BD - Bangladesh 95
RU - Federazione Russa 69
FR - Francia 67
AR - Argentina 48
KR - Corea 48
IN - India 28
MX - Messico 22
DE - Germania 19
EC - Ecuador 19
IQ - Iraq 19
GB - Regno Unito 18
ID - Indonesia 15
CA - Canada 13
PL - Polonia 11
ZA - Sudafrica 11
CL - Cile 10
PK - Pakistan 9
AT - Austria 8
UA - Ucraina 8
NL - Olanda 7
TR - Turchia 7
VE - Venezuela 7
CO - Colombia 6
ES - Italia 6
UZ - Uzbekistan 6
DZ - Algeria 5
EG - Egitto 5
FI - Finlandia 5
LT - Lituania 5
MY - Malesia 5
PY - Paraguay 5
AZ - Azerbaigian 4
GT - Guatemala 4
JM - Giamaica 4
JP - Giappone 4
MA - Marocco 4
PH - Filippine 4
SE - Svezia 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
JO - Giordania 3
NP - Nepal 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
TN - Tunisia 3
BB - Barbados 2
BO - Bolivia 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
BF - Burkina Faso 1
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
KE - Kenya 1
LB - Libano 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
PR - Porto Rico 1
PT - Portogallo 1
SV - El Salvador 1
TG - Togo 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.777
Città #
Singapore 240
Council Bluffs 175
Ashburn 172
Hong Kong 165
Dallas 109
Beijing 93
Ho Chi Minh City 75
San Jose 74
Lauterbourg 59
Los Angeles 53
Hanoi 49
Hefei 48
Seoul 48
São Paulo 48
Boardman 31
New York 29
Redondo Beach 29
Buffalo 28
Santa Clara 25
The Dalles 23
Milan 22
Phoenix 17
Rio de Janeiro 16
Chicago 15
Houston 10
Warsaw 10
Curitiba 9
Baghdad 8
Chennai 8
Atlanta 7
Belo Horizonte 7
Da Nang 7
Denver 7
Frankfurt am Main 7
Orem 7
Thái Bình 7
Amsterdam 6
Brooklyn 6
Dhaka 6
Haiphong 6
Hải Dương 6
Manaus 6
Naples 6
Porto Alegre 6
Rome 6
Xi'an 6
Catania 5
Charlotte 5
Johannesburg 5
Joinville 5
Lahore 5
Miami 5
Newark 5
Thái Nguyên 5
Turin 5
Baku 4
Biên Hòa 4
Brasília 4
Buenos Aires 4
Cairo 4
Campinas 4
Des Moines 4
Guayaquil 4
Mexico City 4
Philadelphia 4
Poplar 4
Salvador 4
Stockholm 4
Suzhou 4
Tashkent 4
Tokyo 4
Udine 4
Acireale 3
Addis Ababa 3
Amman 3
Belluno 3
Bengaluru 3
Boston 3
Caxias do Sul 3
City of London 3
Columbus 3
Córdoba 3
Erbil 3
Guarulhos 3
Guatemala City 3
Itabira 3
Kuala Lumpur 3
Manchester 3
Montreal 3
Phủ Lý 3
Riyadh 3
Salt Lake City 3
San Juan Bautista 3
San Justo 3
Santiago 3
Seattle 3
Sete Lagoas 3
Suzano 3
Turku 3
Uberaba 3
Totale 1.994
Nome #
Primary and Secondary Prophylaxis of Gastrointestinal Bleeding in Children with Portal Hypertension: A Multicenter National Study by SIGENP 115
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis 82
Gene Therapy in Patients with the Crigler-Najjar Syndrome 79
Cardiologic study of 10 patients with Duchenne muscular dystrophy(DMD): personal experience 79
Percutaneous management of chronic total occlusion of the portal vein: a retrospective analysis of technical aspects and outcomes 79
Italian children seem to be spared from the mysterious severe acute hepatitis outbreak: A report by SIGENP Acute Hepatitis Group 78
A Pediatric Emergency Department Protocol to Avoid Intrahospital Spread of SARS-CoV-2 during the Outbreak in Bergamo, Italy 77
Breakthroughs and challenges in the management of pediatric viral hepatitis 75
Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia 73
Analysis of quality of life, hepatic biochemical markers, and sleep in patients with progressive familial intrahepatic cholestasis who had a pruritus response with odevixibat treatment 71
ABO Incompatible Liver Transplantation in Children: A 20 Year Experience from Centres in the TransplantChild European Reference Network 70
Foreign Body Ingestion in Children: A 16-year Experience 69
AUTOIMMUNE ACUTE LIVER FAILURE IN CHILDREN: CLINICAL CLUES AND A NEW DIAGNOSTIC SCORE 68
Acute Liver Failure in Children: Is It Time to Revise the Diagnostic Criteria? 67
Cutting edge issues in juvenile sclerosing cholangitis 66
Biliary features in liver histology of children with autoimmune liver disease 66
A child with congenital heart disease and situs viscerum inversus 66
COVID-19 in Children With Liver Disease 64
Early steroids after pediatric liver transplantation protect against T-cell-mediated rejection: Results from the ChilSFree study 62
EXTRA-HEPATIC PORTAL VEIN OBSTRUCTION IN CHILDREN: A MULTICENTRE NATIONAL STUDY 62
Disease burden and management of Crigler-Najjar syndrome: Report of a world registry 61
Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review 61
Diagnosing Spontaneous Bacterial Peritonitis in Children: Tap-in for Higher Scores 61
Cold Ischemia Time and Graft Fibrosis Are Associated with Autoantibodies after Pediatric Liver Transplantation: A Retrospective Cohort Study of the European Reference Network TransplantChild 60
Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome 59
Diagnosing Acute Cellular Rejection after Paediatric Liver Transplantation—Is There Room for Interleukin Profiles? 58
Paediatric porto-sinusoidal vascular disease: Two different clinical phenotypes with subtle histological differences 55
Scurvy: A disease of anesthetic interest? Scurvy and anesthesia 55
Portal Hypertension in Children 55
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group 54
Munchausen syndrome by proxy 54
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group 53
Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasis 53
Diagnostic Yield of an Algorithm for Neonatal and Infantile Cholestasis Integrating Next-Generation Sequencing 53
Long-term Outcome of Asymptomatic Patients with Graft Fibrosis in Protocol Biopsies after Pediatric Liver Transplantation 53
Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis 52
Outcome of Very Early Onset Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis: A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN 52
Frailty in children with chronic liver disease: Growing evidence for an underexplored topic 51
Septic arthritis in infancy with a good outcome: A study of five patients 50
Seamless Management of Juvenile Autoimmune Liver Disease: Long-Term Medical and Social Outcome 50
Patterns of Presentation of SARS-CoV-2 Infection in Children. Experience at the Italian Epicentre of the Pandemic 49
Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: A multicentre national study 48
Use of oral vancomycin in children with autoimmune liver disease: A single centre experience 48
Cytomegalovirus-RNA Accurately Identifies Clinically Significant Infection Needing Preemptive Therapy in Liver Transplanted Children: A Proof-of-Concept Study 48
ODEVIXIBAT TREATMENT IN PATIENTS WITH RECURRENT EPISODIC CHOLESTASIS AND BIALLELIC MUTATIONS IN ATP8B1: A RETROSPECTIVE CASE SERIES 47
Treatment with an ileal bile acid transporter inhibitor in patients with TJP2 deficiency 47
The frequency of rare and monogenic diseases in pediatric organ transplant recipients in Italy 47
Distinctive Clinical Features of Portal Hypertension in Children with Portal Vein Thrombosis Following Liver Transplantation 47
Identifying the Aetiology of Acute Liver Failure Is Crucial to Impact Positively on Outcome 46
Outcome of Children with Transjugular Intrahepatic Portosystemic Shunt: A Meta-Analysis of Individual Patient Data 45
Severe acute hepatitis and acute liver failure of unknown origin in children: a questionnaire-based study within 34 paediatric liver centres in 22 European countries and Israel 45
Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement 45
Successful management of acute liver failure in Italian children: A 16-year experience at a referral centre for paediatric liver transplantation 45
Impact of the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak on Pediatric Liver Transplant Recipients in Lombardy, Northern Italy 44
Transplant-free Survival in Chronic Liver Disease Presenting as Acute Liver Failure in Childhood 44
Feasibility and Efficacy of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Children 44
Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy 43
Reply to comment: Etiology of non-cirrhotic portal vein thrombosis in children: Few or many causes?  43
Melorheostosis: case report with 20-year follow-up 43
Health status of children with chronic liver disease during the SARS-CoV-2-outbreak: results from a multicentre study' 42
Interobserver Agreement on Endoscopic Classification of Oesophageal Varices in Children 42
Adeno-associated virus vector mediated gene therapy for Crigler Najjar syndrome: preliminary report of safety and efficacy from the CareCN clinical trial 40
Long-term survival in a child with arthrogryposis multiplex congenita and spinal muscular atrophy 40
Longitudinal Immune Phenotype Assessment and Serological Outcome in Foreign-born Children With Chronic Hepatitis B 39
Long-term Outcome of Transjugular Intrahepatic Portosystemic Shunt in Children With Portal Hypertension 38
Fulminant Hepatic Failure of Autoimmune Aetiology in Children 38
Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children 38
Variability in the management of portal hypertension across European countries: A survey-study by ESPGHAN Portal Hypertension Special Interest Group 35
Case numbers of acute hepatitis of unknown aetiology among children in 24 countries up to 18 April 2022 compared to the previous 5 years 35
Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP 34
Odevixibat for Episodic Intrahepatic Cholestasis due to Biallelic Mutations in ATP8B1: A Case Series 33
Diagnosis and management of sclerosing cholangitis and inflammatory bowel disease in children: A survey by SIGENP 27
Intensive care management of children with liver disease 20
Portal hypertension 19
Clinical Course and Outcomes of Paediatric Chronic Hepatitis B: Insights From a Multicenter Longitudinal Cohort of 248 Patients 17
Reply to: “Managing PFIC 7 with odevixibat: Alleviation of pruritus and biochemical response” 12
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF 9
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF 9
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF 8
A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF 8
Hypertransaminasemia in hospitalized children: Insights from a National Multicenter Study by the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition 4
Beyond consensus: Identifying divergences in the care of children with portal hypertension 3
Baveno VIII - Advancing Consensus in Portal Hypertension 1
Totale 4.027
Categoria #
all - tutte 13.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.558


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.017 0 0 0 0 143 30 109 28 86 97 197 327
2025/20262.651 136 380 349 466 289 139 168 114 103 130 223 154
2026/2027359 112 171 76 0 0 0 0 0 0 0 0 0
Totale 4.027